Lahlou N, Roger M, Chaussain J L, Feinstein M C, Sultan C, Toublanc J E, Schally A V, Scholler R
Fondation de Recherche en Hormonologie, Paris, France.
J Clin Endocrinol Metab. 1987 Nov;65(5):946-53. doi: 10.1210/jcem-65-5-946.
Short term treatment with GnRH agonists has been reported to increase plasma gonadotropin alpha-subunit (Gn alpha) levels while decreasing plasma immunoreactive LH (IR-LH) levels. In this study we examined the effect of D-Trp6-LHRH (LHRH-A) in microcapsules (60 micrograms/kg, im, every 28 days for 1 yr) in 13 girls suffering from precocious puberty. Plasma IR-Gn alpha was measured by RIA; plasma IR-LH and IR-FSH were measured by both polyclonal RIAs and monoclonal immunoradiometric assays (IRMA). Before treatment, basal IR-LH and IR-FSH levels and peak responses to LHRH measured by both RIA and IRMA were similar, and the Gn alpha response paralleled that of LH. After the first injection of LHRH-A, RIA LH levels were significantly higher than pretreatment levels until day 21, while IRMA LH levels transiently increased, but returned to pretreatment levels by day 7 and became lower thereafter (P less than 0.005). Plasma IR-Gn alpha levels increased from days 3-21 (P less than 0.05). After 1.5 months of treatment, basal RIA LH levels remained detectable and not different from pretreatment levels; IRMA LH levels were very low. The mean RIA and IRMA LH responses to LHRH were decreased at 1.5 and 12 months (P less than 0.01). Basal plasma RIA and IRMA FSH levels were similar during treatment (P greater than 0.05) and significantly lower than pretreatment values (P less than 0.01). The mean RIA and IRMA FSH responses to LHRH decreased significantly at 1.5 months (P less than 0.001). After 12 months, both RIA and IRMA FSH responses were increased, but IRMA values were significantly lower than RIA values. A sustained increase in basal Gn alpha values occurred, but there was a tendency for the peak levels after LHRH treatment to decrease, becoming significantly lower than pretreatment peak levels after 1 yr. The chromatographic analysis on Sephadex G-100 of a pool of plasma samples collected during a LHRH test in three children treated for 6 months indicated that IR-Gn alpha coeluted with [125I]Gn alpha. The large discrepancy between RIA and IRMA LH values suggests the secretion of unusual LH molecules which are recognized by RIA but not by IRMA. The sustained release of large amounts of IR-Gn alpha indicates dissociated effects of LHRH-A on alpha- and beta-subunit secretion by the gonadotrophs. The sustained response of Gn alpha to LHRH demonstrates that gonadotroph cell LHRH receptors are still responsive to LHRH during treatment with a LHRH agonist.
据报道,用促性腺激素释放激素(GnRH)激动剂进行短期治疗可使血浆促性腺激素α亚基(Gnα)水平升高,同时使血浆免疫反应性促黄体生成素(IR-LH)水平降低。在本研究中,我们检测了微囊化的D-色氨酸6-促黄体生成素释放激素(LHRH-A)(60微克/千克,肌肉注射,每28天一次,共1年)对13名性早熟女孩的影响。用放射免疫分析法(RIA)测定血浆IR-Gnα;用多克隆RIA和单克隆免疫放射测定法(IRMA)测定血浆IR-LH和IR-FSH。治疗前,通过RIA和IRMA测得的基础IR-LH和IR-FSH水平以及对LHRH的峰值反应相似,Gnα反应与LH反应平行。首次注射LHRH-A后,直到第21天,RIA LH水平显著高于治疗前水平,而IRMA LH水平短暂升高,但在第7天恢复到治疗前水平,此后变得更低(P<0.005)。血浆IR-Gnα水平在第3至21天升高(P<0.05)。治疗1.5个月后,基础RIA LH水平仍可检测到,且与治疗前水平无差异;IRMA LH水平非常低。在1.5个月和12个月时,对LHRH的平均RIA和IRMA LH反应降低(P<0.01)。治疗期间基础血浆RIA和IRMA FSH水平相似(P>0.05),且显著低于治疗前值(P<0.01)。在1.5个月时,对LHRH的平均RIA和IRMA FSH反应显著降低(P<0.001)。1